MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Insulet lures Analogic CFO Levitz | Personnel Moves

Insulet lures Analogic CFO Levitz | Personnel Moves

By

Insulet lures Analogic CFO Levitz | Personnel Moves

Insulet (NSDQ:PODD) today said it’s replacing its CFO with the finance chief at Analogic (NSDQ:ALOG), Michael Levitz.

Levitz is slated to succeed Allison Dorval, who’s stepping down "to pursue other professional opportunities," effective May 4, Billerica, Mass.-based Insulet said.

Dorval, who’s been at Insulet since 2008, was controller there when she replaced Brian Roberts last fall. She’s slated to stay on through July 3 to help with the transition, the company said.

"We are grateful to Allison for her many years of service to Insulet. We wish her well in her future endeavors," president & CEO Patrick Sullivan said in prepared remarks.

"Mike has an exceptional work ethic, a deep understanding of the medical device sector and a proven track record of success," Sullivan added. "I am confident he brings the experience and skills to take the Insulet finance team to the next level. His expertise leading global finance organizations will be valuable to the company as we continue to grow our U.S. and international diabetes businesses and capitalize on exciting opportunities to leverage Insulet’s drug delivery technology in new therapeutic areas. Our senior leadership team is focused on executing our strategy to position Insulet for sustained accelerated growth over the long-term, and Mike’s extensive public company CFO experience will significantly enhance our capabilities."

For its part, Analogic said its controller, Michael Bourque, will serve as interim CFO while the Peabody, Mass.-based company looks for a replacement.

"Mike Levitz has been a key member of our senior leadership team during his tenure with our company. Through his efforts, we have developed a strong finance organization that is integral to our company’s success. We wish Mike the very best as he pursues a unique opportunity and enters the next phase of his career," president & CEO Jim Green said in a statement.

"I am very pleased to have the opportunity to work with Pat and the Insulet team. I believe the OmniPod is a truly innovative and differentiated drug delivery platform which not only has the potential to continue winning market share across the global insulin pump market, but also to expand meaningfully into additional drug delivery opportunities, positioning Insulet for long-term growth. I look forward to contributing to Insulet’s success," Levitz said.

 Align Technology CEO Prescott to retire

Align Technology (NSDQ:ALGN)
CEO Thomas Prescott is slated to retire effective June 1, to be replaced by former ABB Ltd. CEO Joseph Hogan. Prescott is set to continue to serve on Align’s board, the company said.

 Reva Medical taps ex-Volcano CEO Huennekens for board
Reva Medical (ASX:RVA) said it tapped the former CEO of Volcano, Scott Huennekens, for a seat on its board of directors. Royal Philips (NYSE:PHG) agreed to pay $1.2 billion for Volcano late last year.
Read more

 Benvenue Medical’s new CFO is a Volcano vet too
Benvenue Medical also nabbed a former Volcano executive, naming former finance chief John Dahldorf to be Benvenue’s new CFO.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Tegra Medical announces new director of sales and marketing in Europe
    Tegra Medical announced that it appointed Darren Vine as its director of sales and marketing in Europe. Franklin, Mass.-based Tegra said in a news release that Vine will report to CEO and head of SFS division medical Walter Kobler, with responsibilities including the building of the company’s presence through expansion into new markets around the… […]
  • 5 challenges Boston Scientific overcame to make single-use scopes work
    FDA wanted single-use scopes to reduce potentially deadly superbug infections. Here’s how Boston Scientific made it happen. Boston Scientific’s Exalt Model D Single-Use Duodenoscope received FDA clearance in December 2019. It was the first device of its kind to hit the medical market. Just five months earlier, the FDA urged device manufacturers to move away from re-usable duodenoscopes with… […]
  • Veranex acquires Experien Group
    Veranex announced today that it acquired Experien Group, a provider of regulatory, quality and clinical consulting services for medtech companies. Raleigh, N.C.-based Veranex, which was created as a combination of companies after Summit Partners acquired Ximedica, Quartesian and Boston Healthcare Associates in June, offers integrated product development strategies and services to medtech companies. According to… […]
  • How Olympus is using AI to find patients for its COPD device
    Olympus recently announced its SeleCT Connect program, which uses diagnostic imaging AI to automatically screen which people might benefit from its Spiration valve system. Spiration is an FDA-designated breakthrough device for treating chronic obstructive pulmonary disease (COPD) patients. SeleCT Connect — offered as part of Olympus’ SeleCT quantitative computer tomography (QCT) analysis service — is… […]
  • Catheter & Medical Design and VitalDyne Medical rebrand as VitalPath
    Catheter & Medical Design and VitalDyne Medical — makers of complex medical catheter systems — have rebranded under the name VitalPath. The move comes about five months after CMD’s March 2021 acquisition of VitalDyne. The Roseville, Minn.–based company also has a new website at vitalpath.com. VitalPath will exhibit at booth  No. 1714 at MD&M West,… […]
  • Dymax touts newest formulations for medtech wearables
    Dymax is using MD&M West in Anaheim, Calif. next week to tout its newest formulations for assembling medical device wearables. The Dymax materials are free from IBOA and TPO, are compatible with common and difficult substrates, and have passed ISO 10993-10 for sensitization and irritation, according to the Torrington, Conn.–based company. For manufacturers involved with… […]
  • What is a proportional isolation valve?
    A “proportional” isolation valve can bring the next level of control and design for engineers, especially in life science industries. Doug Paynter, Clippard When we talk about proportional valves, whether they are pneumatic or hydraulic, we typically refer to valves that vary their flow path when you apply an increasing or decreasing amount of power/current… […]
  • CoorsTek scores EU legal win in pink components trademark dispute
    The EU Trademark Court of Appeals in Paris recently upheld a Paris EU Trademark High Court decision that sided with CoorsTek against CeramTec in a trademark dispute over “pink” ceramic hip components. The Paris Court of Appeals in its June 2021 ruling upheld the cancelations of the three EU trademarks and the dismissal of CeramTec’s… […]
  • Abbott CMO Dr. Nick West touts latest iteration of drug-eluting stent
    Abbott executive Dr. Nick West believes the company offers the “best-in-class” drug-eluting stent with its Xience platform. When Abbott (NYSE:ABT) CMO & divisional VP of global medical affairs Dr. Nick West looks back at his use of drug-eluting stents in the early 2000s, all he sees now is innovation. As a practicing interventional cardiologist, West remembers… […]
  • Versapor® RC Membranes: The next generation of venting materials
    As the world leader in the design and production of membranes, filtration devices, and separation systems, Pall Corporation supplies products to nearly every industry in the world. Founded in 1946, Pall Corporation has set the standard for filtration solutions for 75 years and counting. Our customers have relied on us for their most sophisticated applications… […]
  • Tips to help bring your medical device from mind to market
    By Bret Ludwig, Ph.D. Senior Product Development Specialist, 3M Medical Materials & Technologies Great medical devices start with an idea—a spark. And from there, it might move to the back of a napkin or a notepad. But as development continues, the process can get trickier and more complex. In fact, turning an idea into a… […]

Leave a Reply